Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5294]

Trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

Trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

$FDA grants accelerated approval to pirtobrutinib for relapsed or refractory mantle cell lymphoma$

FDA grants accelerated approval to pirtobrutinib for relapsed or refractory mantle cell lymphoma

FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

FDA approves elacestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer

FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer

Researchers uncover an unexpected T cell exhaustion factor driving cancer immunotherapy resistance

Researchers uncover an unexpected T cell exhaustion factor driving cancer immunotherapy resistance

Artificial human skin paves the way to new skin cancer therapy

Artificial human skin paves the way to new skin cancer therapy

Targeting cancer with a multidrug nanoparticle

Targeting cancer with a multidrug nanoparticle

Keys to making immunotherapy work against pancreatic cancer found in tumour microenvironment

Keys to making immunotherapy work against pancreatic cancer found in tumour microenvironment

Advanced cervical cancer: Pembrolizumab prolongs life

Advanced cervical cancer: Pembrolizumab prolongs life

FDA approves zanubrutinib for chronic lymphocytic leukaemia or small lymphocytic lymphoma

FDA approves zanubrutinib for chronic lymphocytic leukaemia or small lymphocytic lymphoma

More from ecancer